Physician profile
Isha Dave
NPI 1902258957
$638.18
in general payments reported to CMS, 2019-2025
9 companies · $16.45 in 2025
The $16.45 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.66 · 2021: $34.77 · 2022: $93.41 · 2023: $205 · 2024: $195 · 2025: $16.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $129.88 | 2021-2024 | Xarelto |
| Inari Medical, INC. | $110.14 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Scientific Affairs, LLC | $93.66 | 2019 | |
| Novartis Pharmaceuticals Corporation | $70.18 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.03 | 2023-2024 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.44 | 2021-2024 | Jardiance, Stiolto Respimat |
| Gilead Sciences, INC. | $48.20 | 2023-2025 | Veklury |
| Lexicon Pharmaceuticals, INC. | $37.05 | 2023 | Inpefa |
| Pfizer INC. | $13.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isha Dave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.